Sfoglia per Autore "Georgiadou, S. P."
Items 1-16 di 16
-
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome
Zachou, K.; Liaskos, C.; Christodoulou, D. K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S. P.; Tsianos, E. V.; Dalekos, G. N. (2003)Background Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' ... -
Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C
Gatselis, N. K.; Georgiadou, S. P.; Koukoulis, G. K.; Tassopoulos, N.; Zachou, K.; Liaskos, C.; Hatzakis, A.; Dalekos, G. N. (2006)Background: Development of organ- and non-organ-specific autoantibodies has been reported in hepatitis C virus patients treated with interferon-α plus/minus ribavirin. Aims: To address whether prevalence and the titre of ... -
Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece
Georgiadou, S. P.; Velegraki, A.; Arabatzis, M.; Neonakis, I.; Chatzipanagiotou, S.; Dalekos, G. N.; Petinaki, E. (2014)Background: Fusarium spp. can cause disseminated infections, particularly in immuno-compromised patients. Fusarium verticillioides is a human pathogen, and sporadic cases of fusariosis have been reported. Aim: To report a ... -
Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece
Georgiadou, S. P.; Stefos, A.; Spanakos, G.; Skrimpas, S.; Makaritsis, K.; Sipsas, N. V.; Dalekos, G. N. (2015)Objectives: Visceral leishmaniasis (VL) is re-emerging in endemic areas. The epidemiological, clinical, laboratory, and treatment outcome characteristics in a large cohort of VL patients is described herein. Methods: The ... -
Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study
Gatselis, N. K.; Georgiadou, S. P.; Tassopoulos, N.; Zachou, K.; Liaskos, C.; Hatzakis, A.; Dalekos, G. N. (2005)AIM: Various side effects have been reported in patients infected with hepatitis C virus (HCV) who were treated with interferon-alpha (IFN-alpha), including the appearance or exacerbation of underlying autoimmune diseases ... -
Intrafamilial spread of hepatitis B virus infection in Greece
Zervou, E. K.; Gatselis, N. K.; Xanthi, E.; Ziciadis, K.; Georgiadou, S. P.; Dalekos, G. N. (2005)Objective: No study has investigated the intrafamilial spread of hepatitis B virus (HBV) in Greece. We conducted a 9-year prospective study to determine the rate of HBV spread in family members when a member is identified ... -
Lack of association between appendectomy and primary biliary cirrhosis
Rigopoulou, E. I.; Georgiadou, S. P.; Barbanis, S.; Dalekos, G. N. (2006)Objective. In view of the possible implication of various environmental factors in the pathogenesis of primary biliary cirrhosis (PBC), the role of appendectomy in patients with PBC and other chronic liver diseases from ... -
Leptospirosis and pancytopenia: Two case reports and review of the literature
Stefos, A.; Georgiadou, S. P.; Gioti, C.; Loukopoulos, A.; Ioannou, M.; Pournaras, S.; Dalekos, G. N. (2005)Besides the classical manifestations, leptospirosis may rarely occur with erythroid hypoplasia and/or pancytopenia. In this study, we reported two cases of leptospirosis presented with pancytopenia as the prevailing ... -
Markers of hepatitis viruses and human T-lymphotropic virus types I/II in patients who have undergone open-heart surgery: Evidence of increased risk for exposure to HBV and HEV
Zervou, E. K.; Georgiadou, S. P.; Liapi, G. K.; Karabini, F.; Giogiakas, V.; Zisiadis, K.; Gatselis, N. K.; Goudevenos, I.; Dalekos, G. N. (2005)Background: Open-heart procedure is characterized by a high-risk for contracting blood-borne infections. We evaluated the prevalence of several markers of hepatitis viruses (B-E) and human T-cell lymphotropic virus types ... -
Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse non-viral hepatic diseases
Georgiadou, S. P.; Zachou, K.; Rigopoulou, E.; Liaskos, C.; Mina, P.; Gerovasilis, F.; Makri, E.; Dalekos, G. N. (2004) -
Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases
Georgiadou, S. P.; Zachou, K.; Rigopoulou, E.; Liaskos, C.; Mina, P.; Gerovasilis, F.; Makri, E.; Dalekos, G. N. (2004)Occult hepatitis B virus (HBV) infection has been reported in patients with chronic hepatitis C who are negative for HBV surface antigen (HBsAg). However, the significance of 'silent' HBV in hepatitis C virus (HCV) infection ... -
Occult hepatitis B virus infection in patients with autoimmune liver diseases
Georgiadou, S. P.; Zachou, K.; Liaskos, C.; Gabeta, S.; Rigopoulou, E. I.; Dalekos, G. N. (2009)Occult hepatitis B virus (HBV) infection is characterized by undetectable serum HBV surface antigen (HBsAg) but detectable HBV-DNA in serum or liver. To determine the prevalence and clinical impact of occult HBV in autoimmune ... -
Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece
Mina, P.; Georgiadou, S. P.; Rizos, C.; Dalekos, G. N.; Rigopoulou, E. I. (2010)AIM: To assess the hepatitis B virus (HBV)-DNA and the prevalence of occult HBV infection in end-stage renal failure (ESRF) patients from Central Greece. METHODS: Sera from 366 ESRF patients attending five out of six ... -
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: A case report and review of the literature
Tzovaras, N.; Stefos, A.; Georgiadou, S. P.; Gatselis, N.; Papadamou, G.; Rigopoulou, E.; Ioannou, M.; Skoularigis, I.; Dalekos, G. N. (2006)Hepatopulmonary syndrome (HPS) is defined as a clinical triad including liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations. We report a 61-year-old male presented with fatigue, ... -
Reversion of severe hepatopulmonary syndrome in a non cirrhotic patient after corticosteroid treatment for granulomatous hepatitis: A case report and review of the literature
Tzovaras, N.; Stefos, A.; Georgiadou, S. P.; Gatselis, N.; Papadamou, G.; Rigopoulou, E.; Ioannou, M.; Skoularigis, I.; Dalekos, G. N. (2005)Hepatopulmonary syndrome (HPS) is defined as a clinical triad including liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations. We report a 61-year-old male presented with fatigue, ... -
Which level of immunosuppression is harmful for occult hepatitis B virus infection?: 'A million dollar' answer
Georgiadou, S. P.; Dalekos, G. N. (2009)